home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/1f8935a3-3090-4e97-9e3a-1368471a1586_TruTag-Regulatory-Whitepaper_0.pdf
whitepaper
SHARESHARESHARE
REGULATORY CONSIDERATIONS FOR INCORPORATING PCID INTO SODF DRUGS
Unauthorized diversion and falsification of drug products create safety risks in the supply chain, creating life-threatening risk for patients and reducing revenue, profitability and brand equity for drug owners. To reduce the proliferation of counterfeit drugs in the U.S., the Drug Quality and Security Act (DQSA) was signed into law in November 2013. DOWNLOAD